Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-10-01 | 2020-10-24 | 125509 |
TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-10-08 | 2020-11-19 | 126032 |
SEASONIQUE | 0.01MG 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126035 |
SEASONALE | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126038 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-10-15 | 2021-03-04 | 126513 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-15 | 2020-12-03 | 126516 |
TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-10-15 | 2020-11-07 | 126519 |
TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126522 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2020-10-15 | 2020-10-30 | 126527 |
PORTIA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126530 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-22 | 2020-11-26 | 126909 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2020-10-22 | 2020-10-30 | 126915 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-22 | 2021-01-07 | 126939 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2021-04-21 | 126942 |
TEVA-CILAZAPRIL/HCTZ | 5MG 12.5MG | TABLET | Resolved | 2020-10-22 | 2021-04-29 | 126948 |
TEVA-VARENICLINE | 1MG | TABLET | Actual shortage | 2020-10-22 | 2021-07-15 | 126951 |
TEVA-VARENICLINE | 0.5MG 1MG | TABLET | Actual shortage | 2020-10-22 | 2021-07-15 | 126955 |
TEVA-CHLORPROMAZINE | 100MG | TABLET | Resolved | 2020-10-30 | 2020-11-26 | 127604 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |